T 0223/11 (Ibandronic acid/HOFFMANN - LA ROCHE) of 22.5.2012

European Case Law Identifier:

ECLI:EP:BA:2012:T022311.20120522

Date of decision:

22 May 2012

Case number:

T 0223/11

Application number:

03722591.9

IPC class:

A61P 19/10
A61K 31/663

Language of proceedings:

Distribution:

Download and more information:

Decision text in EN (PDF, 52Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	Unpublished

Title of application:

Ibandronic acid for the treatment and prevention of osteoporosis

Applicant name:

F. Hoffmann-La Roche AG

Opponent name:

Laboratorios Liconsa, S.A.
Alfred E. Tiefenbacher GmbH & Co. KG
Teva Pharmaceutical Industries LTD.
Gedeon Richter Plc.
Generics [UK] Limited
Synthon BV
Intervener:
Sandoz FarmacÃªutica, Lda.

Board:

3.3.02

Headnote:

Relevant legal provisions:

European Patent Convention Art 123(2)
European Patent Convention Art 115
European Patent Convention Art 105(1)(a)

Keywords:

All requests: added subject-matter (yes)
Admissibility of intervention (no)
Referral to the Enlarged Board of Appeal (no)

Catchwords:

Cited decisions:

T 0016/05

Citing decisions:

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110223eu1.html